TITLE

765 Is dyssynchrony alone sufficient to identify responders to cardiac resynchronisation therapy

AUTHOR(S)
Parsai, C.; Bijnens, B.; Sutherland, G.R.; Baltabaeva, A.; Claus, P.; Derumeaux, G.; Cannesson, M.; Anderson, L.
PUB. DATE
June 2007
SOURCE
European Journal of Heart Failure. Supplements;
SOURCE TYPE
DOC. TYPE
Abstract
ABSTRACT
An abstract of the study "Is Dyssynchrony Alone Sufficient to Identify Responders to Cardiac Resynchronization Therapy," by C. Parsai and colleagues is presented.
ACCESSION #
25768622

 

Related Articles

  • IS EASY ACCESS BY PRIMARY CARE TO RESPIRATORY CONSULTANTS HELPFUL?  // Thorax;Dec2008 Supplement 7, Vol. 63, pA12 

    An abstract of the article "Is Easy Access by Primary Care to Respiratory Consultants Helpful?" by A.Y.H. Lim and colleagues is presented.

  • 769 Effect of cardiac resynchronization therapy on left ventricular rotation and torsion: an echocardiographic assessment with the novel technique speckle tracking. Yilmazer, M.S.; Aydin, A.; Akyol, A.; Dagdeviren, B. // European Journal of Heart Failure. Supplements; 

    An abstract of the study "Effect of Cardiac Resynchronization Therapy on Left Ventricular Rotation and Torsion: An Echocardiographic Assessment With the Novel Technique Speckle Tracking," by M. S. Yilmazer and colleagues is presented.

  • 756 Cardiac resynchronization therapy in patients with a narrow QRS and evidence of LV dyssynchrony. Taborsky, M.; Neuzil, P.; Schejbalova, M. // European Journal of Heart Failure. Supplements; 

    An abstract of the study "Cardiac Resynchronization Therapy in Patients With a Narrow QRS and Evidence of LV Dyssynchrony," by M. Taborsky and colleagues is presented.

  • SERUM URIC ACID AND CAD: A CONNECTION?  // Cortlandt Forum;02/25/2001, Vol. 14 Issue 2, p84 

    Focuses on the benefits of losartan against coronary artery disease. Uric acid in patients with insulin resistance.

  • Early Invasive Treatment in Patients with Unstable CAD. Walling, Anne D. // American Family Physician;2/1/2000, Vol. 61 Issue 3, p797 

    Discusses research on early invasive treatment in patients with unstable coronary artery disease. Reference to a study from the August 28, 1999 issue of the `Lancet'; Incidence of Myocardial ischemia; Studies conducted on patients with coronary ischemia; Application of invasive treatment to the...

  • Save your life.  // Body Bulletin;Jan1993, p2 

    Discusses why responding quickly to a heart attack is more important than ever now. The new class of clot-busting drugs; How they can actually stop many heart attacks in their tracks and prevent virtually any damage to the heart muscle; Quick delivery; Take an aspirin before you go to the...

  • Yo-yo, no-no.  // Current Health 2;Feb1992, Vol. 18 Issue 6, p23 

    Discusses the health risks of yo-yo dieting. A Yale University study which found that people who had large weight fluctuations over a 32-year period were more likely to develop heart disease; Lost fat and muscle regained only as fat.

  • In defense of imbibing.  // Executive Health's Good Health Report;Jun93, Vol. 29 Issue 9, p8 

    Cites a study which reveals certain regions in France have low incidence of atherosclerosis and heart disease despite a high intake of saturated fatty acids and cholesterol. French paradox; Link to wine consumption at moderate levels; Study to determine how wine's non-alcoholic components...

  • Clot-busting drugs to `turn off' heart... Carey, C. // FDA Consumer;Feb1988, Vol. 22 Issue 1, p22 

    Heart attacks are deadly because they're brought on by clots that block the blood supply to the heart muscle. Growing use of clot-dissolving drugs gives a greater chance of recovery from a heart attack.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics